HOME › DRUGS › SUMATRIPTAN SUCCINATE
ACTIVE SUBSTANCE / INN

SUMATRIPTAN SUCCINATE

Brand name(s): ONZETRA XSAIL, IMITREX, SUMATRIPTAN SUCCINATE, IMITREX STATDOSE, ALSUMA, ZEMBRACE SYMTOUCH, SUMATRIPTAN AND NAPROXEN SODIUM
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA206099
ANDA077696
ACTIVE SUBSTANCE
Sumatriptan Succinate
REGULATORS
FDA
SPONSORS / MAH
TEVA, CHARTWELL MOLECULAR, CURRAX
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SUMATRIPTAN SUCCINATEANDA076840TEVADiscontinued
SUMATRIPTAN SUCCINATEANDA200183HIKMAPrescription
IMITREXNDA020132GLAXOSMITHKLINEPrescription
ZEMBRACE SYMTOUCHNDA208223TONIX MEDSPrescription
SUMATRIPTAN AND NAPROXEN SODIUMANDA090872RISINGPrescription
IMITREX STATDOSENDA020080GLAXOSMITHKLINEPrescription
IMITREXNDA020080GLAXOSMITHKLINEDiscontinued
ALSUMANDA022377MERIDIAN MEDCLDiscontinued
SUMATRIPTAN SUCCINATEANDA077696CHARTWELL MOLECULARNone (Tentative Approval)
ONZETRA XSAILNDA206099CURRAXPrescription

FULL INTELLIGENCE ON SUMATRIPTAN SUCCINATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →